A Phase 3 interventional study of laparoscopic gastric bypass plus omentectomy in Diabetes, Interleukins and Cytokines, sponsored by Legacy Health System. Status unknown at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2007-11-02.
Sponsored by Legacy Health System · Phase 3, Interventional, and Treatment
To see if removing the omentum in addition to a gastric bypass improves diabetes is better than just a gastric bypass.
Legacy Health System is the lead sponsor of 30 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
surgery plus omentectomy
Procedure: laparoscopic gastric bypass plus omentectomy
standard gastric bypass
diabetic indices
Time frame: 6 months
interleukin and cytokine levels, weight loss
Time frame: 6 months
This study is status unknown, as verified in Nov 2007. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Legacy Health System